Vicor PD2i Cardiac Analyzer

Related by string. * Vi COR : Vicor PD2i Analyzer . Vicor PD2i . Vicor Annual Report . Vicor anticipates additional / : PD2i ® nonlinear algorithm . PD2i . PD2i Analyzer ™ . PD2i Cardiac Analyzer / CARDIAC . Cardiacs . cardiac : suffered cardiac arrest . sudden cardiac arrest . sudden cardiac death / analyzing . Analyzing . analyzed : logo NICE Analyzer . logic analyzer . analyzing SF CDOs * *

Related by context. Frequent words. (Click for all words.) 43 substudy 41 cohort 41 prospective cohort 41 METHODS 39 multicenter study 39 randomization 38 subset 38 multicentre 38 randomisation 38 cognitively normal 37 confidence interval #.#-#.# 37 comorbidity 37 meta analysis 37 longitudinal study 37 multicenter randomized double 37 postmenopausal women 37 PCa 36 HCV infected 36 ± SD 36 unique identifier 36 addresses 36 randomized 35 comorbidities 35 randomized controlled clinical 35 composite endpoint 35 longitudinal studies 35 Cohorts 35 HCV genotype 1 35 randomized controlled trial 35 total hip arthroplasty 35 myocardial infarction MI 34 hking@arkansasnews.com 34 vertebral fracture 34 observational study 34 multicenter 34 blinded placebo controlled 34 placebo controlled trials 34 study 34 dose regimens 34 prespecified 33 myocardial infarctions 33 postmenopausal 33 jbrummett@arkansasnews.com 33 prospective randomized 33 covariates 33 NHANES 33 n = 33 ellengoodman@globe.com 33 multicenter clinical 33 confidence interval CI 33 Phase 1b clinical 33 Randomized 33 blind placebo controlled 33 randomized placebo controlled 33 Longitudinal Study 32 Cohort 32 subgroup 32 32 randomized controlled trials 32 events SAEs 32 kidney transplant recipients 32 identifiers 32 randomized clinical 32 RCTs 32 VTE 32 randomized double 32 placebo controlled 32 serum samples 32 knee OA 32 www.comedycentral.com 32 ST elevation myocardial 32 castration resistant prostate cancer 32 prospectively 32 authors conclude 32 subpopulation 32 HbA1c levels 32 RECIST criteria 32 subgroups 31 dose escalation 31 genotyped 31 evaluable 31 completers 31 premenopausal 31 identifies 31 CaP 31 eGFR 31 acute myelogenous leukemia AML 31 randomized trials 31 phase IIa 31 randomized Phase III 31 dose escalation study 31 % CI #.#-#.# [006] 31 http:/www.aa.com 31 microalbuminuria 31 subsample 30 label dose escalation 30 Phase IIa trial 30 P = .# 30 identifier 30 mhamblen@computerworld.com 30 neoadjuvant chemotherapy

Back to home page